Carbetocin Side Effects and Management
Carbetocin is generally well-tolerated with significantly fewer side effects than syntometrine, though hypotension is common and cardiovascular effects require monitoring.
Common Side Effects
The most frequently reported side effects of carbetocin include:
Cardiovascular Effects
- Hypotension is the most common side effect, occurring in approximately 55% of patients receiving standard doses (80-120 μg) 1
- Tachycardia may occur, similar to oxytocin
- Rare but serious: Acute coronary syndrome has been reported, with an incidence of approximately 0.34% (1/245 patients) 2
Gastrointestinal Effects
- Nausea and vomiting occur but are significantly less frequent than with syntometrine 3
- Nausea: RR 0.24 (76% reduction compared to syntometrine)
- Vomiting: RR 0.21 (79% reduction compared to syntometrine)
- Diarrhea may occur slightly more frequently than with oxytocin (RR 8.00), though this is based on limited data 4
Other Effects
- Water retention (similar to oxytocin) 5
- Headache
- Flushing
- Tremor
Comparison with Other Uterotonics
According to the 2026 ERAS guidelines, carbetocin demonstrates a favorable side effect profile compared to alternative uterotonics 5:
- Fewer side effects than syntometrine (which causes hypertension)
- Fewer side effects than carboprost (which causes bronchospasm)
- Similar to oxytocin but with longer duration of action
Management Strategies
Prevention of Side Effects
Optimize dosing: Recent evidence suggests lower doses may be equally effective with fewer side effects. Studies show 80-120 μg doses are similarly effective, suggesting the possibility of using lower doses to minimize hypotension 1.
Administration technique:
- Carbetocin can be safely administered as a short infusion rather than rapid bolus, which does not compromise uterine tone but may reduce cardiovascular side effects 6
- This mirrors recommendations for oxytocin, where slow administration (1 IU per 10 seconds) reduces hemodynamic effects 5
Active Management
For hypotension:
- Maintain euvolemia during cesarean delivery 5
- Have vasopressors readily available
- Monitor blood pressure closely during and after administration
For cardiovascular events:
- Be prepared to manage angina or acute coronary syndrome, though rare 2
- Have resuscitation equipment immediately available
- Consider cardiac monitoring in high-risk patients
For allergic reactions:
- Although less common than with oxytocin, anaphylactic reactions can occur
- Keep epinephrine, corticosteroids, and antihistamines readily available
- Monitor patients closely during the first few minutes after administration
Important Clinical Considerations
Rare but Serious Adverse Events
Placenta interception: An extremely rare complication where carbetocin may cause uterine contraction before placental separation, potentially leading to misdiagnosis as placenta accreta 7. Obstetricians should be aware of this possibility if there are signs of retained placenta after carbetocin administration.
Contraindications and Precautions
While the provided evidence focuses primarily on efficacy, clinicians should:
- Exercise caution in patients with cardiovascular disease given the risk of coronary events
- Monitor patients with previous exposure to platinum therapy more closely (though this relates to carboplatin, not carbetocin - note the drug label evidence 8 appears to be for carboplatin, a chemotherapy agent, not carbetocin the uterotonic)
Key Pitfall to Avoid
Do not confuse carbetocin with carboplatin: The drug labels provided 8 are for carboplatin (a chemotherapy agent) not carbetocin (a uterotonic). These are completely different medications with entirely different side effect profiles. Carbetocin does NOT cause bone marrow suppression, nephrotoxicity, or the severe toxicities associated with carboplatin.
Bottom Line
Carbetocin's side effect profile is favorable compared to other uterotonics, with the main concern being hypotension in about half of patients 1. The significantly lower rates of nausea, vomiting, and hypertension compared to syntometrine make it an attractive option 3. Administer as a slow infusion rather than rapid bolus to minimize cardiovascular effects 6, and maintain vigilance for the rare but serious cardiovascular complications 2.